Evidence map›Paper›PMID 30510314›Full record

ArticleThe Canadian veterinary journal = La revue veterinaire canadienne2018

Radiotherapy and pasireotide treatment of a growth hormone producing pituitary tumor in a diabetic dog.

Francesco Zublena, Alice Tamborini, Carmel T Mooney, Susan M North, Monika A Lobacz, Dan Andrew, Vanessa Woolhead, Heather Covey, Herbert A Schmid, David B Church and 1 more

Abstract readCase Reports
PubMed Full text at PMC
In one paragraph

Article in The Canadian veterinary journal = La revue veterinaire canadienne, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.3field-weighted citation impact, top 34% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 5 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 1 institution in 1 country.

Francesco ZublenaSouthfields Veterinary Specialists, formerly VRCC, Laindon, United Kingdom (Zublena, Tamborini, North, Lobacz); SeersCroft, North Norsham, United Kingdom (Andrew); University Veterinary Hospital, Dublin, Ireland (Mooney); Department of Clinical Science and Services, The Royal Veterinary College, Herts, United Kingdom (Woolhead, Covey, Church, Niessen); Novartis Institutes for BioMedical Research, Oncology Research, Novartis Pharma AG, Basel, Switzerland (Schmid).
Alice TamboriniSouthfields Veterinary Specialists, formerly VRCC, Laindon, United Kingdom (Zublena, Tamborini, North, Lobacz); SeersCroft, North Norsham, United Kingdom (Andrew); University Veterinary Hospital, Dublin, Ireland (Mooney); Department of Clinical Science and Services, The Royal Veterinary College, Herts, United Kingdom (Woolhead, Covey, Church, Niessen); Novartis Institutes for BioMedical Research, Oncology Research, Novartis Pharma AG, Basel, Switzerland (Schmid).
Carmel T MooneySouthfields Veterinary Specialists, formerly VRCC, Laindon, United Kingdom (Zublena, Tamborini, North, Lobacz); SeersCroft, North Norsham, United Kingdom (Andrew); University Veterinary Hospital, Dublin, Ireland (Mooney); Department of Clinical Science and Services, The Royal Veterinary College, Herts, United Kingdom (Woolhead, Covey, Church, Niessen); Novartis Institutes for BioMedical Research, Oncology Research, Novartis Pharma AG, Basel, Switzerland (Schmid).
Susan M NorthSouthfields Veterinary Specialists, formerly VRCC, Laindon, United Kingdom (Zublena, Tamborini, North, Lobacz); SeersCroft, North Norsham, United Kingdom (Andrew); University Veterinary Hospital, Dublin, Ireland (Mooney); Department of Clinical Science and Services, The Royal Veterinary College, Herts, United Kingdom (Woolhead, Covey, Church, Niessen); Novartis Institutes for BioMedical Research, Oncology Research, Novartis Pharma AG, Basel, Switzerland (Schmid).
Monika A LobaczSouthfields Veterinary Specialists, formerly VRCC, Laindon, United Kingdom (Zublena, Tamborini, North, Lobacz); SeersCroft, North Norsham, United Kingdom (Andrew); University Veterinary Hospital, Dublin, Ireland (Mooney); Department of Clinical Science and Services, The Royal Veterinary College, Herts, United Kingdom (Woolhead, Covey, Church, Niessen); Novartis Institutes for BioMedical Research, Oncology Research, Novartis Pharma AG, Basel, Switzerland (Schmid).
Dan AndrewSouthfields Veterinary Specialists, formerly VRCC, Laindon, United Kingdom (Zublena, Tamborini, North, Lobacz); SeersCroft, North Norsham, United Kingdom (Andrew); University Veterinary Hospital, Dublin, Ireland (Mooney); Department of Clinical Science and Services, The Royal Veterinary College, Herts, United Kingdom (Woolhead, Covey, Church, Niessen); Novartis Institutes for BioMedical Research, Oncology Research, Novartis Pharma AG, Basel, Switzerland (Schmid).
Vanessa WoolheadSouthfields Veterinary Specialists, formerly VRCC, Laindon, United Kingdom (Zublena, Tamborini, North, Lobacz); SeersCroft, North Norsham, United Kingdom (Andrew); University Veterinary Hospital, Dublin, Ireland (Mooney); Department of Clinical Science and Services, The Royal Veterinary College, Herts, United Kingdom (Woolhead, Covey, Church, Niessen); Novartis Institutes for BioMedical Research, Oncology Research, Novartis Pharma AG, Basel, Switzerland (Schmid).
Heather CoveySouthfields Veterinary Specialists, formerly VRCC, Laindon, United Kingdom (Zublena, Tamborini, North, Lobacz); SeersCroft, North Norsham, United Kingdom (Andrew); University Veterinary Hospital, Dublin, Ireland (Mooney); Department of Clinical Science and Services, The Royal Veterinary College, Herts, United Kingdom (Woolhead, Covey, Church, Niessen); Novartis Institutes for BioMedical Research, Oncology Research, Novartis Pharma AG, Basel, Switzerland (Schmid).
Herbert A SchmidSouthfields Veterinary Specialists, formerly VRCC, Laindon, United Kingdom (Zublena, Tamborini, North, Lobacz); SeersCroft, North Norsham, United Kingdom (Andrew); University Veterinary Hospital, Dublin, Ireland (Mooney); Department of Clinical Science and Services, The Royal Veterinary College, Herts, United Kingdom (Woolhead, Covey, Church, Niessen); Novartis Institutes for BioMedical Research, Oncology Research, Novartis Pharma AG, Basel, Switzerland (Schmid).
David B ChurchSouthfields Veterinary Specialists, formerly VRCC, Laindon, United Kingdom (Zublena, Tamborini, North, Lobacz); SeersCroft, North Norsham, United Kingdom (Andrew); University Veterinary Hospital, Dublin, Ireland (Mooney); Department of Clinical Science and Services, The Royal Veterinary College, Herts, United Kingdom (Woolhead, Covey, Church, Niessen); Novartis Institutes for BioMedical Research, Oncology Research, Novartis Pharma AG, Basel, Switzerland (Schmid).
Stijn J M NiessenSouthfields Veterinary Specialists, formerly VRCC, Laindon, United Kingdom (Zublena, Tamborini, North, Lobacz); SeersCroft, North Norsham, United Kingdom (Andrew); University Veterinary Hospital, Dublin, Ireland (Mooney); Department of Clinical Science and Services, The Royal Veterinary College, Herts, United Kingdom (Woolhead, Covey, Church, Niessen); Novartis Institutes for BioMedical Research, Oncology Research, Novartis Pharma AG, Basel, Switzerland (Schmid).
Novartis (Switzerland) · CH

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

An 8-year-old castrated male border terrier dog was diagnosed with acromegaly resulting from a growth hormone secreting pituitary tumor. Sixteen daily fractions of radiation therapy were delivered followed, approximately 1 year later, by administration of pasireotide. The aforementioned treatment was considered effective and should be further evaluated in similar cases.

Indexed as

AcromegalyAdenomaAnimalsDiabetes MellitusDog DiseasesDogsGrowth Hormone-Secreting Pituitary AdenomaHormonesMaleSomatostatinTreatment OutcomeHormonespasireotideSomatostatin

Identifiers

PMID30510314
PMCPMC6135304
OpenAlexW3004447257

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.